AcelRx Pharmaceuticals Competitors
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside | Analysts | Market Cap |
|---|---|---|---|---|---|---|---|---|---|
| JNJ | Johnson & Johnson | Outperform |
9
|
$149.70 | Buy/Sell | $174.55 | 13.56% | 3 | $360.28B |
| SUPN | Supernus Pharmaceuticals | Outperform |
16
|
$27.77 | Buy/Sell | $41.00 | 45.84% | 0 | $1.72B |
| ANIP | ANI Pharmaceuticals | Buy |
13
|
$60.36 | Buy/Sell | $69.75 | 32.54% | 1 | $1.38B |
| IRWD | Ironwood Pharmaceuticals | Buy |
14
|
$6.06 | Buy/Sell | $17.83 | 131.02% | 2 | $1.29B |
| COLL | Collegium Pharmaceutical | Outperform |
11
|
$33.82 | Buy/Sell | $37.75 | 18.27% | 1 | $1.24B |
| PCRX | Pacira BioSciences | Outperform |
16
|
$30.32 | Buy/Sell | $47.90 | 45.12% | 6 | $1.23B |
| HRTX | Heron Therapeutics | Buy |
7
|
$3.47 | Buy/Sell | $5.63 | 87.32% | 0 | $442.92M |
| AQST | Aquestive Therapeutics | Buy |
0
|
$3.07 | Buy/Sell | $6.33 | 193.16% | 0 | $307.71M |
| ZVRA | Zevra Therapeutics | Buy |
10
|
$4.49 | Buy/Sell | $19.50 | 312.03% | 1 | $204.66M |
| DRRX | DURECT | Outperform |
9
|
$1.26 | Buy/Sell | $6.75 | 435.71% | 2 | $33.21M |
| CPIX | Cumberland Pharmaceuticals | - |
0
|
$2.03 | Buy/Sell | $8.50 | -100.00% | 0 | $24.38M |
| TRVN | Trevena | Outperform |
2
|
$0.61 | Buy/Sell | $5.18 | 555.74% | 0 | $9.38M |
| ACOR | Acorda Therapeutics | - |
5
|
$0.75 | Buy/Sell | $200.00 | -100.00% | 1 | $0.53M |
| BXRX | Baudax Bio | - |
0
|
$0.01 | Buy/Sell | $24.00 | -100.00% | 0 | $0.53M |
| DMK | DMK Pharmaceuticals | - |
8
|
$0.03 | Buy/Sell | $1.50 | -100.00% | 0 | $0.31M |